{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T02:12:42Z","timestamp":1782439962730,"version":"3.54.5"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"1099","license":[{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives:<\/jats:title>\n                  <jats:p>To evaluate the value of preoperative MRI features and laboratory indicators in predicting the early response of hepatocellular carcinoma (HCC) to transcatheter arterial chemoembolization (TACE) combined with high-intensity focused ultrasound (HIFU) treatment and to establish a preoperative prediction model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>A total of 188 patients with 223 tumors who underwent TACE\/HIFU treatment from January 2011 to June 2017 were included. Tumors were divided into three groups (&amp;lt; 2\u2009cm, 2 \u2013 5\u2009cm,&amp;gt; 5\u2009cm) and classified as non-complete response (NCR) and complete response (CR) cohorts according to the Response Evaluation Criteria in Cancer of the Liver (RECICL) 2015 revised version. Univariate analysis and multivariate logistic regression analysis were used to determine independent predictors, and receiver operating characteristic (ROC) curve analysis was performed to assess the diagnostic power of each predictor. The prediction model was derived on the \u03b2 coefficient of the multivariate regression analysis of the predictors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Irregular margins in the 2 \u2013 5\u2009cm group were closely related to early NCR. Irregular margins, arterial peritumoral enhancement and abnormal alpha-fetoprotein (AFP) were independent predictors of early NCR in the &amp;gt; 5\u2009cm group. The prediction model of this group suggests that irregular margins combined with arterial peritumoral enhancement and abnormal AFP combined with irregular margins and arterial peritumoral enhancement predict an increased risk of early NCR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion:<\/jats:title>\n                  <jats:p>Irregular margins of 2 \u2013 5\u2009cm tumors and irregular margins, arterial peritumoral enhancement, and abnormal AFP of tumors &amp;gt; 5\u2009cm can be applied to predict the early response of HCC to TACE\/HIFU treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Advances in knowledge:<\/jats:title>\n                  <jats:p>TACE combined with HIFU treatment may be able to significantly improve survival in patients with advanced HCC. Conventional MRI features and laboratory indicators are readily available without complex post-processing. It is feasible to predict the response of HCC after TACE\/HIFU treatment based on preoperative conventional MRI features and laboratory indicators, the combination of multiple features predicts high-risk of non-complete response.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1259\/bjr.20190073","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T20:06:50Z","timestamp":1559765210000},"source":"Crossref","is-referenced-by-count":13,"title":["Preoperative MRI features and clinical laboratory indicators for predicting the early therapeutic response of hepatocellular carcinoma to transcatheter arterial chemoembolization combined with High-intensity focused ultrasound treatment"],"prefix":"10.1093","volume":"92","author":[{"given":"Haiping","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Radiology, the Second Affiliated Hospital of Chongqing Medical University , Chongqing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"He","sequence":"additional","affiliation":[{"name":"Department of Radiology, the Second Affiliated Hospital of Chongqing Medical University , Chongqing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Chongqing General Hospital , Chongqing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Radiology, the Second Affiliated Hospital of Chongqing Medical University , Chongqing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjie","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Radiology, the Second Affiliated Hospital of Chongqing Medical University , Chongqing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Radiology, the Second Affiliated Hospital of Chongqing Medical University , Chongqing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Radiology, the Second Affiliated Hospital of Chongqing Medical University , Chongqing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajing","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Radiology, the Second Affiliated Hospital of Chongqing Medical University , Chongqing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,6,5]]},"reference":[{"key":"2024050214465955100_b1","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jvir.2014.03.007","article-title":"Efficacy and nontarget effects of transarterial chemoembolization in bridging of hepatocellular carcinoma patients to liver transplantation: a histopathologic study","volume":"25","author":"Stampfl","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"2024050214465955100_b2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00270-007-9270-8","article-title":"Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome","volume":"31","author":"Herber","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2024050214465955100_b3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/hpb.12025","article-title":"Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma","volume":"15","author":"Cheung","year":"2013","journal-title":"HPB"},{"key":"2024050214465955100_b4","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/j.ejca.2010.06.015","article-title":"Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma","volume":"46","author":"Li","year":"2010","journal-title":"Eur J Cancer"},{"key":"2024050214465955100_b5","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00261-017-1072-0","article-title":"CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma","volume":"42","author":"Zhou","year":"2017","journal-title":"Abdom Radiol"},{"key":"2024050214465955100_b6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3346\/jkms.2015.30.7.965","article-title":"MRI findings and prediction of time to progression of patients with hepatocellular carcinoma treated with drug-eluting bead transcatheter arterial chemoembolization","volume":"30","author":"Lee","year":"2015","journal-title":"J Korean Med Sci"},{"key":"2024050214465955100_b7","first-page":"689","article-title":"The quantitative analysis of Mr dynamic contrast-enhangced imaging on efficacy and prognosis of transcatheter arterial chemoembolization on hepatocellular carcinoma","volume":"39","author":"Ma","year":"2017","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"2024050214465955100_b8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.mri.2014.03.003","article-title":"Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result","volume":"32","author":"Park","year":"2014","journal-title":"Magn Reson Imaging"},{"key":"2024050214465955100_b9","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.2147\/OTT.S112555","article-title":"Predictive values of diffusion-weighted imaging and perfusion-weighted imaging in evaluating the efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma","volume":"9","author":"Lin","year":"2016","journal-title":"Onco Targets Ther"},{"key":"2024050214465955100_b10","first-page":"2375","article-title":"Predictive values of serum VEGF and CRP levels combined with contrast enhanced MRI in hepatocellular carcinoma patients after TACE","volume":"6","author":"Li","year":"2016","journal-title":"Am J Cancer Res"},{"key":"2024050214465955100_b11","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7819-11-212","article-title":"Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy","volume":"11","author":"Ma","year":"2013","journal-title":"World J Surg Oncol"},{"key":"2024050214465955100_b12","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.3892\/ol.2017.6489","article-title":"Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization","volume":"14","author":"Douhara","year":"2017","journal-title":"Oncol Lett"},{"key":"2024050214465955100_b13","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"European association for the study of the liver, European Organisation for research and treatment of cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"2024050214465955100_b14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/hepr.12542","article-title":"Response evaluation criteria in cancer of the liver (RECICL) (2015 revised version","volume":"46","author":"Kudo","year":"2016","journal-title":"Hepatol Res"},{"key":"2024050214465955100_b15","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/sim.1742","article-title":"Presentation of multivariate data for clinical use: the Framingham study risk score functions","volume":"23","author":"Sullivan","year":"2004","journal-title":"Stat Med"},{"key":"2024050214465955100_b16","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1007\/s00330-015-3982-y","article-title":"Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma","volume":"26","author":"Vesselle","year":"2016","journal-title":"Eur Radiol"},{"key":"2024050214465955100_b17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1148\/radiol.2015150998","article-title":"Can current preoperative imaging be used to detect microvascular invasion of hepatocellular carcinoma?","volume":"279","author":"Renzulli","year":"2016","journal-title":"Radiology"},{"key":"2024050214465955100_b18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.dld.2015.11.010","article-title":"Laparoscopic ablation therapies or hepatic resection in cirrhotic patients with small hepatocellular carcinoma","volume":"48","author":"Santambrogio","year":"2016","journal-title":"Dig Liver Dis"},{"key":"2024050214465955100_b19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1440-1746.2008.05596.x","article-title":"Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas","volume":"24","author":"Ohmoto","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"2024050214465955100_b20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00534-010-0369-y","article-title":"A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma","volume":"18","author":"Ariizumi","year":"2011","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2024050214465955100_b21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1148\/radiol.15142394","article-title":"Single hepatocellular carcinoma: preoperative MR imaging to predict early recurrence after curative resection","volume":"276","author":"An","year":"2015","journal-title":"Radiology"},{"key":"2024050214465955100_b22","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1007\/s00330-009-1331-8","article-title":"Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI?","volume":"19","author":"Kim","year":"2009","journal-title":"Eur Radiol"},{"key":"2024050214465955100_b23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/liv.12898","article-title":"Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC","volume":"36","author":"Li","year":"2016","journal-title":"Liver Int"},{"key":"2024050214465955100_b24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00261-011-9685-1","article-title":"Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis","volume":"36","author":"Matsui","year":"2011","journal-title":"Abdom Imaging"},{"key":"2024050214465955100_b25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1148\/radiol.14132362","article-title":"CT and MR imaging diagnosis and staging of hepatocellular carcinoma: Part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features","volume":"273","author":"Choi","year":"2014","journal-title":"Radiology"},{"key":"2024050214465955100_b26","first-page":"787","article-title":"Prognostic factors and model of primary liver cancer treated with transcatheter arterial chemoembolization combined with radiofrequency ablation","volume":"39","author":"Li","year":"2017","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"2024050214465955100_b27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3892\/etm_00000076","article-title":"Effects of pre-operative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: implication of circulating cancer cells by detection of \u03b1-fetoprotein mRNA","volume":"1","author":"Murakami","year":"2010","journal-title":"Exp Ther Med"},{"key":"2024050214465955100_b28","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1053\/j.gastro.2008.02.090","article-title":"Diagnosis and treatment of hepatocellular carcinoma","volume":"134","author":"El-Serag","year":"2008","journal-title":"Gastroenterology"},{"key":"2024050214465955100_b29","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jhep.2011.11.020","article-title":"Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis","volume":"56","author":"Memon","year":"2012","journal-title":"J Hepatol"},{"key":"2024050214465955100_b30","doi-asserted-by":"crossref","first-page":"e0135298","DOI":"10.1371\/journal.pone.0135298","article-title":"Propensity score matching analysis of changes in alpha-fetoprotein levels after combined radiotherapy and transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus","volume":"10","author":"Jeong","year":"2015","journal-title":"PLoS One"},{"key":"2024050214465955100_b31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jss.2016.10.005","article-title":"Alpha fetoprotein changes predict hepatocellular carcinoma survival beyond the Milan criteria after hepatectomy","volume":"209","author":"Shen","year":"2017","journal-title":"J Surg Res"},{"key":"2024050214465955100_b32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev.med.60.041707.170303","article-title":"MRI-guided focused ultrasound surgery","volume":"60","author":"Jolesz","year":"2009","journal-title":"Annu Rev Med"}],"container-title":["The British Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/92\/1099\/20190073\/57378330\/bjr.20190073.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/92\/1099\/20190073\/57378330\/bjr.20190073.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T15:04:22Z","timestamp":1714662262000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjr\/article\/doi\/10.1259\/bjr.20190073\/7448886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,5]]},"references-count":32,"journal-issue":{"issue":"1099","published-online":{"date-parts":[[2019,6,5]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1259\/bjr.20190073","relation":{},"ISSN":["0007-1285","1748-880X"],"issn-type":[{"value":"0007-1285","type":"print"},{"value":"1748-880X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7,1]]},"published":{"date-parts":[[2019,6,5]]},"article-number":"20190073"}}